Publication year
2011Source
Oncotarget, 2, 1-2, (2011), pp. 99-101ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Tumorimmunology
Paediatrics - OUD tm 2017
Journal title
Oncotarget
Volume
vol. 2
Issue
iss. 1-2
Page start
p. 99
Page end
p. 101
Subject
NCMLS 3: Tissue engineering and pathology; ONCOL 2: Age-related aspects of cancer; ONCOL 3: Translational research NCMLS 2: Immune RegulationAbstract
Eradication of cancer stem cells to abrogate tumor growth is a new treatment modality. However, like normal cells cancer cells show plasticity. Differentiated tumor stem cells can acquire stem cell properties when they gain access to the stem cell niche. This indicates that eradicating of stem cells (emptying of the niche) alone will not lead to eradication of the tumor. Treatment should be directed to cancer stem cells and more mature cancer cells.
This item appears in the following Collection(s)
- Academic publications [232165]
- Faculty of Medical Sciences [89075]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.